Incidental Mutation 'R2204:Sars2'
ID 238910
Institutional Source Beutler Lab
Gene Symbol Sars2
Ensembl Gene ENSMUSG00000070699
Gene Name seryl-aminoacyl-tRNA synthetase 2
Synonyms D7Ertd353e, 2410015F05Rik
MMRRC Submission 040206-MU
Accession Numbers
Essential gene? Probably essential (E-score: 0.880) question?
Stock # R2204 (G1)
Quality Score 225
Status Not validated
Chromosome 7
Chromosomal Location 28441417-28453296 bp(+) (GRCm39)
Type of Mutation missense
DNA Base Change (assembly) T to C at 28449099 bp (GRCm39)
Zygosity Heterozygous
Amino Acid Change Valine to Alanine at position 302 (V302A)
Ref Sequence ENSEMBL: ENSMUSP00000092216 (fasta)
Gene Model predicted gene model for transcript(s): [ENSMUST00000094632] [ENSMUST00000207877]
AlphaFold Q9JJL8
Predicted Effect possibly damaging
Transcript: ENSMUST00000094632
AA Change: V302A

PolyPhen 2 Score 0.954 (Sensitivity: 0.79; Specificity: 0.95)
SMART Domains Protein: ENSMUSP00000092216
Gene: ENSMUSG00000070699
AA Change: V302A

DomainStartEndE-ValueType
Pfam:Seryl_tRNA_N 58 174 3.8e-8 PFAM
Pfam:tRNA-synt_2b 284 468 5.2e-24 PFAM
Predicted Effect probably benign
Transcript: ENSMUST00000207877
Predicted Effect noncoding transcript
Transcript: ENSMUST00000207897
Coding Region Coverage
  • 1x: 99.2%
  • 3x: 98.7%
  • 10x: 97.5%
  • 20x: 95.8%
Validation Efficiency
MGI Phenotype FUNCTION: [Summary is not available for the mouse gene. This summary is for the human ortholog.] This gene encodes the mitochondrial seryl-tRNA synthethase precursor, a member of the class II tRNA synthetase family. The mature enzyme catalyzes the ligation of Serine to tRNA(Ser) and participates in the biosynthesis of selenocysteinyl-tRNA(sec) in mitochondria. The enzyme contains an N-terminal tRNA binding domain and a core catalytic domain. It functions in a homodimeric form, which is stabilized by tRNA binding. This gene is regulated by a bidirectional promoter that also controls the expression of mitochondrial ribosomal protein S12. Both genes are within the critical interval for the autosomal dominant deafness locus DFNA4 and might be linked to this disease. Multiple transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Mar 2009]
Allele List at MGI
Other mutations in this stock
Total: 62 list
GeneRefVarChr/LocMutationPredicted EffectZygosity
A630076J17Rik A G 3: 107,140,943 (GRCm39) probably benign Het
Abca1 G A 4: 53,090,291 (GRCm39) T386I probably damaging Het
Acsf3 C T 8: 123,540,383 (GRCm39) S527F probably damaging Het
Adamts7 A T 9: 90,062,729 (GRCm39) K394N probably damaging Het
Ankrd2 C A 19: 42,032,558 (GRCm39) A273E probably damaging Het
Ankrd26 T A 6: 118,500,843 (GRCm39) H876L possibly damaging Het
Atg16l1 A C 1: 87,694,737 (GRCm39) Q138P probably benign Het
Bap1 T C 14: 30,978,658 (GRCm39) V23A probably benign Het
Cartpt A T 13: 100,037,133 (GRCm39) S4T probably benign Het
Cdan1 C A 2: 120,551,241 (GRCm39) C1093F probably damaging Het
Ceacam11 C T 7: 17,709,273 (GRCm39) T157I possibly damaging Het
Cfap45 T C 1: 172,359,728 (GRCm39) V76A probably benign Het
Chil3 T C 3: 106,071,562 (GRCm39) D34G probably benign Het
Chrnb4 G A 9: 54,951,132 (GRCm39) R44C probably damaging Het
Col6a4 T C 9: 105,937,331 (GRCm39) D1395G probably damaging Het
Cpa1 A G 6: 30,641,818 (GRCm39) D214G probably damaging Het
Cttnbp2 T G 6: 18,408,693 (GRCm39) D976A probably benign Het
Elapor1 C T 3: 108,382,359 (GRCm39) G270E probably damaging Het
Espl1 A G 15: 102,214,340 (GRCm39) E693G probably damaging Het
Fat1 G T 8: 45,476,737 (GRCm39) A1928S probably damaging Het
Fiz1 C T 7: 5,011,685 (GRCm39) E278K probably benign Het
Flnc C T 6: 29,459,507 (GRCm39) P2536S probably damaging Het
Gm6370 T A 5: 146,430,539 (GRCm39) D241E probably benign Het
Hlcs T C 16: 94,032,011 (GRCm39) T451A probably benign Het
Hmgcr A G 13: 96,793,141 (GRCm39) L497P probably damaging Het
Hmgcs2 T A 3: 98,198,499 (GRCm39) I134N probably damaging Het
Ifit1bl1 C T 19: 34,571,741 (GRCm39) E239K probably benign Het
Ift52 G A 2: 162,873,150 (GRCm39) S221N probably benign Het
Knstrn T A 2: 118,661,456 (GRCm39) probably null Het
Map3k14 T A 11: 103,130,280 (GRCm39) K212N possibly damaging Het
Ndufb7 A G 8: 84,297,528 (GRCm39) H61R probably damaging Het
Nop56 T A 2: 130,119,488 (GRCm39) I51N probably damaging Het
Nudt5 A T 2: 5,860,794 (GRCm39) I22F possibly damaging Het
Or10j2 T A 1: 173,097,703 (GRCm39) probably null Het
Or4p23 C G 2: 88,576,953 (GRCm39) G93A probably benign Het
Or7d11 T C 9: 19,966,507 (GRCm39) N84S possibly damaging Het
P3h4 G A 11: 100,304,832 (GRCm39) A185V probably benign Het
Pdcl A T 2: 37,242,056 (GRCm39) N231K probably benign Het
Plcb4 T C 2: 135,844,514 (GRCm39) I144T probably benign Het
Pramel32 A T 4: 88,546,355 (GRCm39) L329Q probably damaging Het
Prrc2b C A 2: 32,113,476 (GRCm39) Q1970K probably damaging Het
Robo4 CGG CG 9: 37,322,786 (GRCm39) probably null Het
Shroom3 G T 5: 93,090,945 (GRCm39) V1151F probably damaging Het
Spata31d1d A G 13: 59,879,435 (GRCm39) C34R possibly damaging Het
Speg A T 1: 75,407,121 (GRCm39) T3137S probably benign Het
Ssh3 A G 19: 4,319,101 (GRCm39) L3P probably damaging Het
Stard9 GAAA GAA 2: 120,529,012 (GRCm39) probably null Het
Stoml2 G T 4: 43,030,243 (GRCm39) Y119* probably null Het
Susd1 A G 4: 59,349,843 (GRCm39) L531P possibly damaging Het
Taco1 C T 11: 105,962,760 (GRCm39) A149V probably benign Het
Tenm3 T C 8: 49,127,585 (GRCm39) E31G probably benign Het
Tmc1 A T 19: 20,918,269 (GRCm39) L2M probably benign Het
Tmem39b A C 4: 129,587,716 (GRCm39) S32A probably benign Het
Tnfsf14 T C 17: 57,497,638 (GRCm39) D198G possibly damaging Het
Trabd2b T C 4: 114,460,191 (GRCm39) L443P probably damaging Het
Trip4 T A 9: 65,771,547 (GRCm39) I328F probably damaging Het
Trpc3 A G 3: 36,704,298 (GRCm39) F553S possibly damaging Het
Tssk2 A G 16: 17,716,603 (GRCm39) D2G possibly damaging Het
Ttn T C 2: 76,601,985 (GRCm39) N18559S possibly damaging Het
Vmn1r23 T C 6: 57,903,604 (GRCm39) D58G probably benign Het
Zbtb47 A G 9: 121,591,703 (GRCm39) T8A possibly damaging Het
Zfyve27 C A 19: 42,171,885 (GRCm39) A139D probably damaging Het
Other mutations in Sars2
AlleleSourceChrCoordTypePredicted EffectPPH Score
IGL00907:Sars2 APN 7 28,452,848 (GRCm39) unclassified probably benign
IGL01376:Sars2 APN 7 28,449,308 (GRCm39) missense probably damaging 1.00
IGL01633:Sars2 APN 7 28,446,974 (GRCm39) missense probably benign 0.02
IGL02121:Sars2 APN 7 28,451,950 (GRCm39) unclassified probably benign
IGL02488:Sars2 APN 7 28,441,585 (GRCm39) nonsense probably null
IGL03062:Sars2 APN 7 28,446,206 (GRCm39) missense possibly damaging 0.89
R1601:Sars2 UTSW 7 28,448,396 (GRCm39) missense probably benign 0.26
R1857:Sars2 UTSW 7 28,449,437 (GRCm39) missense probably benign 0.00
R1859:Sars2 UTSW 7 28,443,737 (GRCm39) missense probably damaging 0.99
R2193:Sars2 UTSW 7 28,448,422 (GRCm39) missense probably damaging 0.96
R4452:Sars2 UTSW 7 28,449,518 (GRCm39) missense probably benign 0.08
R4514:Sars2 UTSW 7 28,441,709 (GRCm39) critical splice donor site probably null
R4921:Sars2 UTSW 7 28,451,863 (GRCm39) missense possibly damaging 0.81
R5121:Sars2 UTSW 7 28,447,333 (GRCm39) missense probably damaging 0.99
R5434:Sars2 UTSW 7 28,449,716 (GRCm39) missense probably null 1.00
R5849:Sars2 UTSW 7 28,443,683 (GRCm39) missense possibly damaging 0.92
R6668:Sars2 UTSW 7 28,446,429 (GRCm39) missense probably benign 0.01
R7123:Sars2 UTSW 7 28,452,866 (GRCm39) missense probably benign 0.40
R7205:Sars2 UTSW 7 28,443,733 (GRCm39) missense probably benign
R7677:Sars2 UTSW 7 28,446,176 (GRCm39) missense probably benign 0.07
R7902:Sars2 UTSW 7 28,441,628 (GRCm39) missense probably benign 0.29
R8084:Sars2 UTSW 7 28,449,710 (GRCm39) missense probably damaging 1.00
R8320:Sars2 UTSW 7 28,446,293 (GRCm39) missense probably damaging 1.00
R9057:Sars2 UTSW 7 28,446,246 (GRCm39) missense
R9350:Sars2 UTSW 7 28,447,273 (GRCm39) missense probably damaging 1.00
R9461:Sars2 UTSW 7 28,449,438 (GRCm39) missense probably benign 0.00
Predicted Primers PCR Primer
(F):5'- GAAGTCAGTCACAGTGTGGG -3'
(R):5'- CTGCCATTACCCACAGGAAG -3'

Sequencing Primer
(F):5'- CAGCTATTGGATGGGTCACAC -3'
(R):5'- GTCAGTGAGATTTCAAGTAGAACCCC -3'
Posted On 2014-10-02